Finland Artificial Intelligence (AI) in Healthcare Market Analysis
insights10marketing
81 views
64 slides
Aug 06, 2024
Slide 1 of 64
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
About This Presentation
This report presents a strategic analysis of Finland Artificial Intelligence (AI) in Healthcare Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges...
Slide Content
Finland Artificial
Intelligence (AI) in
Healthcare Market
Analysis
Sample Report
July 2024
Intelligence (AI) in
Healthcare Market
Analysis
Sample Report
July 2024
This report presents a strategic analysis of Finland Artificial
Intelligence (AI) in Healthcare Market and a forecast for its
development in the medium and long term. It provides a comprehensive
overview of the market value, dynamics, segmentation, main players,
growth and demand drivers, challenges & future outlook, etc. This is
one of the most comprehensive reports about Finland Artificial
Intelligence (AI) in Healthcare Market, and offers unmatched value,
accuracy, and expert insights.
Intelligence (AI) in Healthcare Market and a forecast for its
development in the medium and long term. It provides a comprehensive
overview of the market value, dynamics, segmentation, main players,
growth and demand drivers, challenges & future outlook, etc. This is
one of the most comprehensive reports about Finland Artificial
Intelligence (AI) in Healthcare Market, and offers unmatched value,
accuracy, and expert insights.
3 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive
Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement
Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Currency Conversion 1 Euro = 1.08 USD
Research Approach Secondary Research (90%), Primary Research (10%)
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Size & Forecasting, Market Segmentation, Growth Factors and Trends, Competitive
Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement
Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Currency Conversion 1 Euro = 1.08 USD
Research Approach Secondary Research (90%), Primary Research (10%)
Report Scope
4 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
CONTENT PG. NO.
1. Market Overview 6-14
1.1 Artificial Intelligence(AI) in Healthcare Overview
1.2 Artificial Intelligence(AI) in Healthcare Market Overview: Global
1.3 Economic Overview: Finland
1.4 Artificial Intelligence(AI) in Healthcare Market Overview :Finland
1.5 Healthcare Overview: Finland
1.6 Budget of Tanzania Government for Public Insurance
1.7 Top Developments in Finland
2. Technologies and Future of AI 15-17
2.1 Technologies
2.2 Future of AI
3. Market Size and Forecasting 18-23
3.1 Finland Artificial Intelligence in Healthcare Market Size and Forecasts
Table of Content
CONTENT PG. NO.
1. Market Overview 6-14
1.1 Artificial Intelligence(AI) in Healthcare Overview
1.2 Artificial Intelligence(AI) in Healthcare Market Overview: Global
1.3 Economic Overview: Finland
1.4 Artificial Intelligence(AI) in Healthcare Market Overview :Finland
1.5 Healthcare Overview: Finland
1.6 Budget of Tanzania Government for Public Insurance
1.7 Top Developments in Finland
2. Technologies and Future of AI 15-17
2.1 Technologies
2.2 Future of AI
3. Market Size and Forecasting 18-23
3.1 Finland Artificial Intelligence in Healthcare Market Size and Forecasts
Table of Content
5 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
CONTENT PG. NO.
3.2 Snapshot of Tanzania Artificial Intelligence in Healthcare Market Segmentation
3.2.1 Market Segmentation: By Component
3.2.2 Market Segmentation: By Application
3.2.3 Market Segmentation: By Technology
4. Market Dynamics 24-29
4.1 Market Growth Drivers
4.2 Market Growth Restraints
5. Competitive Landscape 30-37
5.1 Key Players in Finland Artificial Intelligence in Healthcare Market
6. Regulatory and Reimbursement Landscape 38-43
6.1 Regulatory Landscape in Finland
6.2 Reimbursement Scenario in Finland
6.3 Reimbursement Process
Table of Content
CONTENT PG. NO.
3.2 Snapshot of Tanzania Artificial Intelligence in Healthcare Market Segmentation
3.2.1 Market Segmentation: By Component
3.2.2 Market Segmentation: By Application
3.2.3 Market Segmentation: By Technology
4. Market Dynamics 24-29
4.1 Market Growth Drivers
4.2 Market Growth Restraints
5. Competitive Landscape 30-37
5.1 Key Players in Finland Artificial Intelligence in Healthcare Market
6. Regulatory and Reimbursement Landscape 38-43
6.1 Regulatory Landscape in Finland
6.2 Reimbursement Scenario in Finland
6.3 Reimbursement Process
Table of Content
Finland Artificial Intelligence (AI) in Healthcare Market Analysis
1. Market Overview
1. Market Overview
▪AI in healthcare refers to using machine learning, deep learning, natural language processing, and
other AI techniques to analyze complex medical data
▪This data can include patient records, medical images, sensors, and even wearables
▪AI in healthcare includes imaging analysis tools for radiologists, virtual assistants for patient
inquiries, robot-assisted surgery, and AI-driven drug discovery and development.
Benefits of AI in healthcare are:
•Enhanced accuracy and efficiency in diagnosis
•Improved prediction of health risks for preventive care
•Development of personalized medicine for better treatment outcomes
•Streamlined healthcare operations and reduced costs
•Improved patient engagement and education
1.1 Artificial Intelligence (AI) in Healthcare Market Overview
Illustrative
other AI techniques to analyze complex medical data
▪This data can include patient records, medical images, sensors, and even wearables
▪AI in healthcare includes imaging analysis tools for radiologists, virtual assistants for patient
inquiries, robot-assisted surgery, and AI-driven drug discovery and development.
Benefits of AI in healthcare are:
•Enhanced accuracy and efficiency in diagnosis
•Improved prediction of health risks for preventive care
•Development of personalized medicine for better treatment outcomes
•Streamlined healthcare operations and reduced costs
•Improved patient engagement and education
1.1 Artificial Intelligence (AI) in Healthcare Market Overview
Illustrative
8 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Private Investment in AI Globally (In $Bn)
1.2 Artificial Intelligence (AI) in Healthcare Market Overview: Global (1/2)
30 %
Of world’s data
stemming from
healthcare industry by
2027
55%
Profit increase in healthcare
by 2035 due to AI according
to Accenture
154 Bn
Worldwide spending on
AI-centric systems in
2023
9.9 Mn
Physicians, Nurses and
Midwives shortfall globally
by 2030
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022
Private Investment in AI Globally (In $Bn)
1.2 Artificial Intelligence (AI) in Healthcare Market Overview: Global (1/2)
30 %
Of world’s data
stemming from
healthcare industry by
2027
55%
Profit increase in healthcare
by 2035 due to AI according
to Accenture
154 Bn
Worldwide spending on
AI-centric systems in
2023
9.9 Mn
Physicians, Nurses and
Midwives shortfall globally
by 2030
9 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Finland Market
~$xx Bn Market
Illustrative
1.2 Artificial Intelligence (AI) in Healthcare Market Overview: Global (2/2)
Finland Market
~$xx Bn Market
Illustrative
1.2 Artificial Intelligence (AI) in Healthcare Market Overview: Global (2/2)
10 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
15%
61%
25%
Population of Finland, (In Mn)
-0.4
0.5
2.8
3.2
1.1
1.2
-2.4
2.8
1.3
-1.0
2013201420152016201720182019202020212022
GDP Growth of Finland (In %)
Population Split (2023)
0-14
15-64
65+
49%
51%
By Age GroupBy Gender
▪Finland is an aging country, as its median age is 42.8 years
which is higher than global median age
▪Country's population’s global share is 0.07% and it is increasing
at a rate of 0.09%
▪Life expectancy of female is 85 years and for male it is 80 years
▪Currently 87.2% of population is urban in Finland
▪Top 3 largest cities are Helsinki, Espoo, Tampere
Illustrative
1.3 Economic Overview: Finland
Male
Female
5.46
5.48
5.50
5.515.51
5.52
5.53
5.54
5.56
5.58
2014201520162017201820192020202120222023
15%
61%
25%
Population of Finland, (In Mn)
-0.4
0.5
2.8
3.2
1.1
1.2
-2.4
2.8
1.3
-1.0
2013201420152016201720182019202020212022
GDP Growth of Finland (In %)
Population Split (2023)
0-14
15-64
65+
49%
51%
By Age GroupBy Gender
▪Finland is an aging country, as its median age is 42.8 years
which is higher than global median age
▪Country's population’s global share is 0.07% and it is increasing
at a rate of 0.09%
▪Life expectancy of female is 85 years and for male it is 80 years
▪Currently 87.2% of population is urban in Finland
▪Top 3 largest cities are Helsinki, Espoo, Tampere
Illustrative
1.3 Economic Overview: Finland
Male
Female
5.46
5.48
5.50
5.515.51
5.52
5.53
5.54
5.56
5.58
2014201520162017201820192020202120222023
11 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
20 20
21 21
22 22 22
23 23
24
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
65+ Population in the Finland (In %)
1.4 Artificial Intelligence (AI) in Healthcare Market Overview: Finland (1/2)
24%
Population of people
aged 60 and older in
2023
49%
Reported having at least one
chronic condition in 2019
84
AI applications in Finnish
healthcare in 2022
$5616
Current health
expenditure per capita in
2021
Illustrative
20 20
21 21
22 22 22
23 23
24
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
65+ Population in the Finland (In %)
1.4 Artificial Intelligence (AI) in Healthcare Market Overview: Finland (1/2)
24%
Population of people
aged 60 and older in
2023
49%
Reported having at least one
chronic condition in 2019
84
AI applications in Finnish
healthcare in 2022
$5616
Current health
expenditure per capita in
2021
Illustrative
12 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
1.5 Healthcare Overview: Finland
Public Healthcare
Structure
›Funding: Public healthcare in Finland is predominantly
funded through general taxation
›Administration: The Ministry of Health oversees the
system, with municipalities known as hospital districts
managing services regionally
›Services: Public healthcare covers hospital care,
emergency services, maternity care, and specialist care,
with affordable co-payments for some services
Access
›Eligibility: All Finnish citizens, permanent residents, and
some work visa holders are eligible for public healthcare
›Cost: Many services, including hospital stays and
emergency care, are free or subsidized
Private Healthcare
Structure
›Funding: Private healthcare is primarily patient-funded,
though some costs may be covered by private insurance
or employer benefits
›Administration: Private healthcare is delivered by
independent providers operating outside the public
system, including clinics, hospitals, and specialists
›Services: Private providers offer a similar range of
services as public ones but may have more advanced
technology and a wider selection
Access
›Wait times: Private healthcare typically offers shorter wait
times, especially for specialist care
›Costs: Private healthcare services are generally more
expensive, with no co-payments, requiring full payment by
the patient
Illustrative
1.5 Healthcare Overview: Finland
Public Healthcare
Structure
›Funding: Public healthcare in Finland is predominantly
funded through general taxation
›Administration: The Ministry of Health oversees the
system, with municipalities known as hospital districts
managing services regionally
›Services: Public healthcare covers hospital care,
emergency services, maternity care, and specialist care,
with affordable co-payments for some services
Access
›Eligibility: All Finnish citizens, permanent residents, and
some work visa holders are eligible for public healthcare
›Cost: Many services, including hospital stays and
emergency care, are free or subsidized
Private Healthcare
Structure
›Funding: Private healthcare is primarily patient-funded,
though some costs may be covered by private insurance
or employer benefits
›Administration: Private healthcare is delivered by
independent providers operating outside the public
system, including clinics, hospitals, and specialists
›Services: Private providers offer a similar range of
services as public ones but may have more advanced
technology and a wider selection
Access
›Wait times: Private healthcare typically offers shorter wait
times, especially for specialist care
›Costs: Private healthcare services are generally more
expensive, with no co-payments, requiring full payment by
the patient
Illustrative
13 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending
accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
1.6 Budget of Finland Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending
accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
1.6 Budget of Finland Government for Public Insurance
14 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Company Name Type Year Key Pointers
Partnership Feb, 2023
▪Better, a digital health platform company, is working with Tietoevry to
provide over 60 healthcare centers in Finland with the Lifecare clinical
system based on the Better Platform and openEHR standard
▪This has improved care efficiency and quality for almost 2 Mn citizens
Partnership Feb, 2023
▪Openehr, a data-centric architecture standard, is being used as the basis
for health data persistence infrastructure in Finland and other Nordic
countries, enabling innovative digital health solutions
Latest Deals in Finland
Illustrative
1.7 Top Developments in Finland
Company Name Type Year Key Pointers
Partnership Feb, 2023
▪Better, a digital health platform company, is working with Tietoevry to
provide over 60 healthcare centers in Finland with the Lifecare clinical
system based on the Better Platform and openEHR standard
▪This has improved care efficiency and quality for almost 2 Mn citizens
Partnership Feb, 2023
▪Openehr, a data-centric architecture standard, is being used as the basis
for health data persistence infrastructure in Finland and other Nordic
countries, enabling innovative digital health solutions
Latest Deals in Finland
Illustrative
1.7 Top Developments in Finland
Finland Artificial Intelligence (AI) in Healthcare Market Analysis
2. Technologies and Future of AI in healthcare
2. Technologies and Future of AI in healthcare
16 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
2.1 Technologies
•Branch of Artificial Intelligence that uses an algorithm to examine previous data,
current information and interactions
Machine Learning
•Deep learning is a subset of machine learning that uses multilayered neural networks
and imitates human brain
Deep Learning
•Process of understanding and interpreting text or language by a machine and can be
used to interpret human language
Natural Language Processing
(NLP)
•Adjust responses based on analyzed data context, improving interactions and outputs
in content management, information retrieval, user experiences, and decision-making
systems
Content-Aware Computing
Illustrative
2.1 Technologies
•Branch of Artificial Intelligence that uses an algorithm to examine previous data,
current information and interactions
Machine Learning
•Deep learning is a subset of machine learning that uses multilayered neural networks
and imitates human brain
Deep Learning
•Process of understanding and interpreting text or language by a machine and can be
used to interpret human language
Natural Language Processing
(NLP)
•Adjust responses based on analyzed data context, improving interactions and outputs
in content management, information retrieval, user experiences, and decision-making
systems
Content-Aware Computing
Illustrative
17 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Illustrative
2.2 Future of AI in healthcare
▪AI-powered drug discovery with personalized medicine approaches: AI algorithms analyze vast molecular data
sets to accelerate drug discovery and development, tailoring treatments to individual genetic profiles for personalized
medicine
▪AI-driven robotics for complex surgical procedures: Advanced AI-driven robotic systems assist surgeons in
performing complex surgeries with greater precision, minimally invasive techniques, and improved patient outcomes
▪AI-powered mental health chatbots and virtual therapists: AI mental health chatbots and virtual therapists
provide accessible, real-time support and therapy for mental health issues, enhancing traditional care methods
▪Wider adoption of AI-powered wearables for continuous health monitoring: AI-powered wearables are
increasingly used for continuous health monitoring, tracking vital signs, and providing real-time health insights to
users and healthcare providers
Illustrative
2.2 Future of AI in healthcare
▪AI-powered drug discovery with personalized medicine approaches: AI algorithms analyze vast molecular data
sets to accelerate drug discovery and development, tailoring treatments to individual genetic profiles for personalized
medicine
▪AI-driven robotics for complex surgical procedures: Advanced AI-driven robotic systems assist surgeons in
performing complex surgeries with greater precision, minimally invasive techniques, and improved patient outcomes
▪AI-powered mental health chatbots and virtual therapists: AI mental health chatbots and virtual therapists
provide accessible, real-time support and therapy for mental health issues, enhancing traditional care methods
▪Wider adoption of AI-powered wearables for continuous health monitoring: AI-powered wearables are
increasingly used for continuous health monitoring, tracking vital signs, and providing real-time health insights to
users and healthcare providers
Finland Artificial Intelligence (AI) in Healthcare Market Analysis
3. Market Size and Forecasting
3. Market Size and Forecasting
19 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Finland Artificial Intelligence (AI) in Healthcare Market Forecast, 2023-2030
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Finland Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Finland Market Size ($Bn) 61 74 84 87 91 95 99 106
Illustrative
3.1 Finland Artificial Intelligence (AI) in Healthcare Market Size and Forecasts
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Finland Artificial Intelligence (AI) in Healthcare Market Forecast, 2023-2030
2023 2024 2025 2026 2027 2028 2029 2030
Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Finland Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937
Finland Market Size ($Bn) 61 74 84 87 91 95 99 106
Illustrative
3.1 Finland Artificial Intelligence (AI) in Healthcare Market Size and Forecasts
20 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪In this section you will get an understanding of the segmentations which will cover the Finland Artificial Intelligence (AI) in Healthcare
Market
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Component
Hardware
Software
Services
Applications
Diagnostics
Drug Discovery and Development
Robot Assisted Surgery
Others
Technology
Machine Learning
Natural Language Processing
Deep Learning
Context-Aware Computing
Illustrative
3.2 Snapshot of Finland Artificial Intelligence (AI) in Healthcare Market
Segmentation
▪In this section you will get an understanding of the segmentations which will cover the Finland Artificial Intelligence (AI) in Healthcare
Market
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Component
Hardware
Software
Services
Applications
Diagnostics
Drug Discovery and Development
Robot Assisted Surgery
Others
Technology
Machine Learning
Natural Language Processing
Deep Learning
Context-Aware Computing
Illustrative
3.2 Snapshot of Finland Artificial Intelligence (AI) in Healthcare Market
Segmentation
21 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Finland AI in Healthcare Market Share, By Component
(2023)
Hardware
Software
Services
Illustrative
3.2.1 Market Segmentation: By Component
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Finland AI in Healthcare Market Share, By Component
(2023)
Hardware
Software
Services
Illustrative
3.2.1 Market Segmentation: By Component
22 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Finland Artificial Intelligence (AI) in Healthcare Market Share, By
Applications (2023)
Diagnostics
Drug Discovery
and
Development
Robot-Assisted
Surgery
Patient
Transportation
Others
Illustrative
3.2.2 Market Segmentation: By Application
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Finland Artificial Intelligence (AI) in Healthcare Market Share, By
Applications (2023)
Diagnostics
Drug Discovery
and
Development
Robot-Assisted
Surgery
Patient
Transportation
Others
Illustrative
3.2.2 Market Segmentation: By Application
23 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Finland Artificial Intelligence (AI) in Healthcare Market Share, By
Technology (2023)
Machine
Learning
Natural
Language
Processing
Healthcare at
Home
Deep Learning
Content-Aware
Computing
Illustrative
3.2.3 Market Segmentation: By Technology
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Finland Artificial Intelligence (AI) in Healthcare Market Share, By
Technology (2023)
Machine
Learning
Natural
Language
Processing
Healthcare at
Home
Deep Learning
Content-Aware
Computing
Illustrative
3.2.3 Market Segmentation: By Technology
Finland Artificial Intelligence (AI) in Healthcare Market Analysis
4. Market Dynamics
4. Market Dynamics
25 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Illustrative
4.1.1
Data solutions can
cut Finland's
healthcare costs by
hundreds of millions
of euros
4.1.2
84 AI applications in
Finnish healthcare
in 2022
4.1.3
Over 24% of
Finland's population
is 65 and older in
2023
4.2.1
High cost of
implementing AI
can be a restraint in
healthcare market
4.2.2
Data privacy and
security concern
limits AI technology
adoption and usage
4. Snapshot Of Market Growth Drivers And Restraints
Illustrative
4.1.1
Data solutions can
cut Finland's
healthcare costs by
hundreds of millions
of euros
4.1.2
84 AI applications in
Finnish healthcare
in 2022
4.1.3
Over 24% of
Finland's population
is 65 and older in
2023
4.2.1
High cost of
implementing AI
can be a restraint in
healthcare market
4.2.2
Data privacy and
security concern
limits AI technology
adoption and usage
4. Snapshot Of Market Growth Drivers And Restraints
26 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Illustrative
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
4.1 Market Growth Drivers
4.1.1 New data-driven solutions can reduce Finland’s annual healthcare costs by hundreds of millions of euros, while
also freeing up time for doctors and nurses to spend with patients
Decrease healthcare expenditure
Illustrative
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
4.1 Market Growth Drivers
4.1.1 New data-driven solutions can reduce Finland’s annual healthcare costs by hundreds of millions of euros, while
also freeing up time for doctors and nurses to spend with patients
Decrease healthcare expenditure
27 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
2010 2022 2030
Illustrative
4.1 Market Growth Drivers
4.1.2 In 2022, Theseus identified 84 AI applications in Finnish healthcare, primarily aiding professionals, patient
monitoring, and screening
Increase In Demand
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
2010 2022 2030
Illustrative
4.1 Market Growth Drivers
4.1.2 In 2022, Theseus identified 84 AI applications in Finnish healthcare, primarily aiding professionals, patient
monitoring, and screening
Increase In Demand
28 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1 Market Growth Drivers
4.1.3 In 2023, over 24% of Finland's population is aged 65 and older, reflecting significant demographic aging
Aging Population
▪Please be aware that this sample report is intended to provide you with a
brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking,
you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data,
analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1 Market Growth Drivers
4.1.3 In 2023, over 24% of Finland's population is aged 65 and older, reflecting significant demographic aging
Aging Population
29 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
4.2.1 Integrating AI technologies into healthcare entails
substantial costs, necessitating significant investments
in hardware, software, and training
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
4.2.2 Challenges in handling sensitive patient data create
barriers, hindering trust and broader AI adoption in
healthcare among providers and patients
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
4.2 Market Growth Restraints
4.2.1 Integrating AI technologies into healthcare entails
substantial costs, necessitating significant investments
in hardware, software, and training
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
4.2.2 Challenges in handling sensitive patient data create
barriers, hindering trust and broader AI adoption in
healthcare among providers and patients
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business
operations and growth.
Illustrative
4.2 Market Growth Restraints
Finland Artificial Intelligence (AI) in Healthcare Market Analysis
5. Competitive Landscape
5. Competitive Landscape
31 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Here is the list of top 10 companies which
will cover in the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
GE Healthcare1 Aidoc6
Siemens Healthineers2 AiCure7
IBM Watson3 APIXIO, Inc8
Philips Healthcare4 Sonocare9
NVIDIA5 HUS Helsinki10
Illustrative
Global Player Local Player
5.1 Key Players in Finland Artificial Intelligence (AI) in Healthcare Market
▪Here is the list of top 10 companies which
will cover in the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
GE Healthcare1 Aidoc6
Siemens Healthineers2 AiCure7
IBM Watson3 APIXIO, Inc8
Philips Healthcare4 Sonocare9
NVIDIA5 HUS Helsinki10
Illustrative
Global Player Local Player
5.1 Key Players in Finland Artificial Intelligence (AI) in Healthcare Market
32 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Founded In: 1892
HQ: Chicago, US
Type: Public
Revenue: $19.06 Bn (Global)
Website: gehealthcare.com
▪GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator
▪It is a leader in global healthcare market, growing 4-6% per year
▪GE HealthCare’s business unit includes Imaging, Ultrasound,
Patient Care Solutions and Pharmaceutical Diagnostics
▪GE uses AI to analyze sensor data from aircraft engines
▪GE prioritizes using AI to solve real-world problems in its core
businesses like aviation, energy, and healthcare.
Offerings
➢Medical Technology
➢Healthcare Technology
Management
➢Clinical Network Solutions
➢Healthcare Financial Services
Recent Activity / Press Coverage
▪June 10, 2024 —GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers.
▪It has named Roland Rott president and CEO of Imaging and Phil Rackliffe president and CEO of Ultrasound and IGT
▪June 07, 2024 — GE HealthCare increases access to precision care tools, encouraging the continued adoption and practice of more personalized
medicine around the world
▪It has announced the development of its new MINItrace Magni, designed to be a small footprint, cost-effective cyclotron for reliable, in-house production
of commercial PET tracers and radiometals – like Gallium-68 – through solid target technology
▪May 22, 2024 — GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations
▪FDA’s list of AI-enabled device authorizations includes more than 850 devices; 72 are from GE HealthCare – more than any other medical technology
company
5.2.1 GE Healthcare (Continued)
Founded In: 1892
HQ: Chicago, US
Type: Public
Revenue: $19.06 Bn (Global)
Website: gehealthcare.com
▪GE HealthCare is a leading global medical technology,
pharmaceutical diagnostics, and digital solutions innovator
▪It is a leader in global healthcare market, growing 4-6% per year
▪GE HealthCare’s business unit includes Imaging, Ultrasound,
Patient Care Solutions and Pharmaceutical Diagnostics
▪GE uses AI to analyze sensor data from aircraft engines
▪GE prioritizes using AI to solve real-world problems in its core
businesses like aviation, energy, and healthcare.
Offerings
➢Medical Technology
➢Healthcare Technology
Management
➢Clinical Network Solutions
➢Healthcare Financial Services
Recent Activity / Press Coverage
▪June 10, 2024 —GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers.
▪It has named Roland Rott president and CEO of Imaging and Phil Rackliffe president and CEO of Ultrasound and IGT
▪June 07, 2024 — GE HealthCare increases access to precision care tools, encouraging the continued adoption and practice of more personalized
medicine around the world
▪It has announced the development of its new MINItrace Magni, designed to be a small footprint, cost-effective cyclotron for reliable, in-house production
of commercial PET tracers and radiometals – like Gallium-68 – through solid target technology
▪May 22, 2024 — GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations
▪FDA’s list of AI-enabled device authorizations includes more than 850 devices; 72 are from GE HealthCare – more than any other medical technology
company
5.2.1 GE Healthcare (Continued)
33 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Company Name Type Year Key Pointers
Acquisition
June 11,
2024
▪Goal: Improve care protocols for CT, MR, and ultrasound systems in
Mexico and Central America
▪Focus: Enhance efficiency and effectiveness of healthcare delivery at
Salud Digna's 200+ clinics
▪Method: Utilize digital solutions to optimize clinical workflows and patient
care
▪Benefit: Streamline healthcare delivery for both clinicians and patients
Partnership
May 30,
2024
▪Partners: GE HealthCare (medical technology) and Tampa General
Hospital (academic health system)
▪Action: Expanding long-term partnership
▪Goal: Benefit patients and clinicians across Florida
▪Method: Deploying GE HealthCare's Imaging and Ultrasound technology
in TGH Imaging's outpatient facilities
Latest Deals in GE Healthcare
Illustrative
5.2.1 GE Healthcare (Continued)
Company Name Type Year Key Pointers
Acquisition
June 11,
2024
▪Goal: Improve care protocols for CT, MR, and ultrasound systems in
Mexico and Central America
▪Focus: Enhance efficiency and effectiveness of healthcare delivery at
Salud Digna's 200+ clinics
▪Method: Utilize digital solutions to optimize clinical workflows and patient
care
▪Benefit: Streamline healthcare delivery for both clinicians and patients
Partnership
May 30,
2024
▪Partners: GE HealthCare (medical technology) and Tampa General
Hospital (academic health system)
▪Action: Expanding long-term partnership
▪Goal: Benefit patients and clinicians across Florida
▪Method: Deploying GE HealthCare's Imaging and Ultrasound technology
in TGH Imaging's outpatient facilities
Latest Deals in GE Healthcare
Illustrative
5.2.1 GE Healthcare (Continued)
34 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.2.1 GE Healthcare (Continued)
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.2.1 GE Healthcare (Continued)
35 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Founded In:
HQ:
Type:
Revenue:
Website:
Offerings
Recent Activity / Press Coverage
5.2.2 Company 2
Illustrative
Founded In:
HQ:
Type:
Revenue:
Website:
Offerings
Recent Activity / Press Coverage
5.2.2 Company 2
Illustrative
36 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Company Name Type Year Key Pointers
Latest Deals in CompanyName
Illustrative
5.2.2 Company 2 (Continued)
Company Name Type Year Key Pointers
Latest Deals in CompanyName
Illustrative
5.2.2 Company 2 (Continued)
37 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.2.2 Company 2 (Continued)
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2023
1 2 3 4
Illustrative
5.2.2 Company 2 (Continued)
Finland Artificial Intelligence (AI) in Healthcare Market Analysis
6. Regulatory and Reimbursement Landscape
6. Regulatory and Reimbursement Landscape
39 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Illustrative
Regulatory Authorities With Jurisdiction Over Drugs, Biologicals, And Medical Devices In Finland
6.1 Regulatory Landscape in Finland
1. Medicines Regulation
Finnish Medicines Agency (Fimea): Fimea, the central authority for regulating human and veterinary drugs in Finland, evaluates and
approves new medications for market use. It monitors these drugs throughout their lifecycle to ensure safety and effectiveness and
maintains a secure supply chain to prevent shortages and ensure consistent quality
2. Medical Devices Regulation
Finnish Safety and Chemicals Agency (Tukes): Tukes is tasked with ensuring the safety and quality of medical devices available
in Finland. It grants marketing authorization to medical devices, ensuring they meet stringent safety and efficacy standards before they can
be sold. Tukes also conducts ongoing market surveillance to monitor the performance and safety of medical devices already in use. This
continuous oversight helps in identifying and mitigating any potential risks associated with medical devices
3. Healthcare Professionals and Facilities Regulation
National Supervisory Authority for Welfare and Health (Valvira): Valvira is responsible for regulating healthcare professionals,
ensuring they possess the necessary qualifications and adhere to high standards of practice. It oversees healthcare facilities to ensure they
provide safe, high-quality care to patients. Valvira also works to maintain and improve the overall quality and safety of healthcare services in
Finland, ensuring compliance with national healthcare standards and guidelines
Illustrative
Regulatory Authorities With Jurisdiction Over Drugs, Biologicals, And Medical Devices In Finland
6.1 Regulatory Landscape in Finland
1. Medicines Regulation
Finnish Medicines Agency (Fimea): Fimea, the central authority for regulating human and veterinary drugs in Finland, evaluates and
approves new medications for market use. It monitors these drugs throughout their lifecycle to ensure safety and effectiveness and
maintains a secure supply chain to prevent shortages and ensure consistent quality
2. Medical Devices Regulation
Finnish Safety and Chemicals Agency (Tukes): Tukes is tasked with ensuring the safety and quality of medical devices available
in Finland. It grants marketing authorization to medical devices, ensuring they meet stringent safety and efficacy standards before they can
be sold. Tukes also conducts ongoing market surveillance to monitor the performance and safety of medical devices already in use. This
continuous oversight helps in identifying and mitigating any potential risks associated with medical devices
3. Healthcare Professionals and Facilities Regulation
National Supervisory Authority for Welfare and Health (Valvira): Valvira is responsible for regulating healthcare professionals,
ensuring they possess the necessary qualifications and adhere to high standards of practice. It oversees healthcare facilities to ensure they
provide safe, high-quality care to patients. Valvira also works to maintain and improve the overall quality and safety of healthcare services in
Finland, ensuring compliance with national healthcare standards and guidelines
40 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Key Legislation
The key legislations for the drug industry in Finland are Health Insurance Act (2004), Act on the Dental and Pharmaceutical Benefits Agency
(TLV) (2009:726), Medicinal Products Act (2015:315), Regulations Implementing EU MDR and IVDR (2017)
Authorization
▪Health Insurance Act (2004): Governs the reimbursement of healthcare services, including AI technologies, by defining
eligible services, criteria for reimbursement, and application processes
▪Act on the Dental and Pharmaceutical Benefits Agency (TLV) (2009:726):Establishes the TLV, which evaluates the
benefits and cost-effectiveness of AI applications and sets reimbursement levels and guidelines
▪Medicinal Products Act (2015:315): Focuses on the safety and quality of pharmaceuticals and AI-based medical devices,
influencing reimbursement by ensuring only effective technologies are considered
▪Regulations Implementing EU MDR and IVDR (2017): Implements EU standards for AI-based medical devices, ensuring
compliance with safety and performance requirements as a prerequisite for reimbursement
Illustrative
Regulatory Framework For The Authorization, Pricing, And Reimbursement Of Drugs
6.2 Reimbursement Scenario in CountryName
Key Legislation
The key legislations for the drug industry in Finland are Health Insurance Act (2004), Act on the Dental and Pharmaceutical Benefits Agency
(TLV) (2009:726), Medicinal Products Act (2015:315), Regulations Implementing EU MDR and IVDR (2017)
Authorization
▪Health Insurance Act (2004): Governs the reimbursement of healthcare services, including AI technologies, by defining
eligible services, criteria for reimbursement, and application processes
▪Act on the Dental and Pharmaceutical Benefits Agency (TLV) (2009:726):Establishes the TLV, which evaluates the
benefits and cost-effectiveness of AI applications and sets reimbursement levels and guidelines
▪Medicinal Products Act (2015:315): Focuses on the safety and quality of pharmaceuticals and AI-based medical devices,
influencing reimbursement by ensuring only effective technologies are considered
▪Regulations Implementing EU MDR and IVDR (2017): Implements EU standards for AI-based medical devices, ensuring
compliance with safety and performance requirements as a prerequisite for reimbursement
Illustrative
Regulatory Framework For The Authorization, Pricing, And Reimbursement Of Drugs
6.2 Reimbursement Scenario in CountryName
41 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in Finland healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
6.2 Reimbursement Scenario in Finland (Continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in Finland healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
6.2 Reimbursement Scenario in Finland (Continued)
42 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
The reimbursement process in Finland healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
6.3 Reimbursement Process
The reimbursement process in Finland healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
6.3 Reimbursement Process
43 A Sample Report on Finland Artificial Intelligence (AI) in Healthcare Market Analysis I Confidential
The reimbursement process in Finland healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
6.3 Reimbursement Process (Continued)
The reimbursement process in Finland healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
6.3 Reimbursement Process (Continued)
A division
of
of
Life-sciences Market Research
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.
At Insights10, our extensive report
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& Drugs)
Click on the country to see the reports
available
Global Coverage
North America
•US
•Canada
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco
available
Global Coverage
North America
•US
•Canada
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco
What do our reports cover?
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10
01 0302 04 05
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process
Bottom Up Approach
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation
2023
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.
We have access to a multitude of highly
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases
Reliable
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works
Yearly Access
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services
“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team
@Our Team
@Work
Beyond Work
… and many more
Pi-SM
GmbH
Our Clients
Pi-SM
GmbH
Our Clients
I've had the pleasure of availing Insights10’s services several times, and I've always
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say
Dear Insights10 Team, I wanted to thank you all for the great work you conducted
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say
Michael Blumberg Youssef Mallat
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.
What our clients say
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Drugs Market. The insights provided by Insights10 is
fantastic and they just took less than three days to deliver the report.
What our clients say
Thank You
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?
Download
Download Slideshow Get the original presentation fileQuick Actions
Statistics
- Views 81
- Slides 64
- Age 482 days
Related Slideshows
11
8-top-ai-courses-for-customer-support-representatives-in-2025.pptx
JeroenErne2
44 views
10
7-essential-ai-courses-for-call-center-supervisors-in-2025.pptx
JeroenErne2
44 views
13
25-essential-ai-courses-for-user-support-specialists-in-2025.pptx
JeroenErne2
36 views
11
8-essential-ai-courses-for-insurance-customer-service-representatives-in-2025.pptx
JeroenErne2
33 views
21
Know for Certain
DaveSinNM
19 views
17
PPT OPD LES 3ertt4t4tqqqe23e3e3rq2qq232.pptx
novasedanayoga46
23 views